-

DeciBio Analytics launches Dexter, an expert network marketplace for the life science industry

LOS ANGELES--(BUSINESS WIRE)--DeciBio Analytics, the market intelligence subsidiary of DeciBio Consulting, a precision medicine strategy consulting firm, has launched an expert network marketplace named Dexter. The launch follows Dexter’s successful beta release a year ago. Dexter customers receive market intelligence by leveraging Dexter’s life science expert network for 1:1 interviews and pulse surveys. Dexter offers an end to end research project solution, from finding relevant experts and scheduling interviews, to processing payments. “We envision Dexter becoming businesses’ go-to resource for quick access to industry experts’ insights,” says Jessica Lee, a product manager who oversees Dexter’s development.

The Dexter network spans various life science cohorts including - but not limited to - single cell genomics, liquid biopsy, pathology, proteomics, and oncology. Examples of past and current projects include:

- Cancer Screening Landscape:

To understand the competitive landscape for early detection and cancer screening in hematology/oncology, users leveraged Dexter to identify and interview 25 stakeholders in the US and EU in four weeks.

- Nanopore Sequencing Analysis:

To characterize adoption, use cases, and pricing of nanopore sequencing instruments in comparison to other NGS technologies, Dexter onboarded 10 US and EU stakeholders in less than three weeks.

- Pharma R&D Assessment:

To characterize pharma R&D allocations and clinical decision support, Dexter users launched an interview campaign for 50 stakeholders in the US, the EU, and Asia.

Dexter offers 2 types of service offerings. The self-service model provides flexibility for customers to lead and conduct their own primary research campaigns. Alternatively, the full-service model includes supplemental services such as interview guides, interview moderation, and summaries.

To learn more about the Dexter expert network or schedule a demo, visit https://dexterexperts.com/ .

About DeciBio

DeciBio Consulting is a strategy consulting firm focused on precision medicine. DeciBio offers advisory services for growth planning, market and opportunity assessment, product and portfolio strategy, and corporate due diligence.

About DeciBio Analytics

DeciBio Consulting’s market intelligence subsidiary, DeciBio Analytics aggregates public and proprietary data to build proprietary data visualization and software products.

Contacts

Jessica Lee
Jessica.lee@decibio.com
310-451-4510

More News From DeciBio Consulting, LLC

Worldwide In Vitro Diagnostics (IVD) Market Forecasted to Grow at 4% p.a., Reaching $109B by 2030 – Market Report by DeciBio Consulting LLC

LOS ANGELES--(BUSINESS WIRE)--According to a comprehensive market report authored by DeciBio Consulting LLC, “In Vitro Diagnostic (IVD) Market Report 2025-2030”, the global in vitro diagnostics market is predicted to reach $109B by 2030. This growth will be driven by increasing access to and adoption of diagnostics, the development of new therapies requiring ongoing testing, and the rise of emerging technologies (e.g., computational pathology, liquid biopsy) poised to gain clinical traction and...

Proteomics Tools Market Forecast to Grow at ~4% p.a., Reaching ~$39B by 2030 – Market Report by DeciBio Consulting LLC

LOS ANGELES--(BUSINESS WIRE)--DeciBio Consulting LLC, a leading market intelligence and strategy consulting firm, announced the publication of its first edition, “Proteomics Tools Report: Research and Clinical markets (2025-2030).” This comprehensive report forecasts the global proteomics tools market to reach approximately $39 billion by 2030, growing at a compound annual growth rate (CAGR) of ~4% from an estimated $32 billion in 2025. DeciBio’s Proteomics Tools Market Report offers an in-dept...

Pharma R&D Services Market Forecast to Grow at 5% p.a., Reaching ~$129B by 2029 – Market Report by DeciBio Consulting LLC

LOS ANGELES--(BUSINESS WIRE)--DeciBio Consulting LLC, a leading market intelligence and strategy consulting firm, announced the publication of its first edition, “Pharma R&D Services Market Report (2024-2029).” This comprehensive report forecasts the global pharma R&D services market to reach approximately $129 billion by 2029, growing at a compound annual growth rate (CAGR) of 5% from an estimated $101 billion in 2024. DeciBio’s Pharma R&D Services Market Report offers an in-depth...
Back to Newsroom